Exact Sciences
EXAS
$104.91
+0.95%
EXAS
Exact Sciences
$104.91
EXAS price trend
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Exact Sciences's 12-month outlook, with a consensus price target around $136.38 and implied upside of +30.0% versus the current price.
Average Target
$136.38
6 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
6
covering this stock
Price Range
$84 - $136
Analyst target range
Drowning in data?
Find the real signal!
EXAS Technical Analysis
Beta
1.44
1.44x market volatility
Max Drawdown
-29.6%
Largest decline past year
52-Week Range
$39-$105
Price range past year
Annual Return
+136.9%
Cumulative gain past year
| Period | EXAS Return | S&P 500 |
|---|---|---|
| 1m | +1.5% | -0.3% |
| 3m | +3.0% | -2.0% |
| 6m | +96.8% | +3.5% |
| 1y | +136.9% | +36.2% |
| ytd | +3.1% | -0.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
EXAS Fundamental Analysis
Quarterly Revenue
$878381000.0B
2025-12
Revenue YoY Growth
+23.1%
YoY Comparison
Gross Margin
70.1%
Latest Quarter
Free Cash Flow
$356782000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is EXAS Overvalued?
PE
-92.2x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -2118x~3880x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
169.2x
Enterprise Value Multiple
